Studies have shown that neoadjuvant nivolumab may provide long-term benefits for people with non-small cell lung cancer.

Published Date: 17 Feb 2023

BACKGROUND: NSCLC is the most common and important cause of cancer worldwide. Assessment: The patient...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Lung nodules seen in a high percentage of non-smokers

2.

Providing essential cancer care to rural communities

3.

Report: Breast cancer mortality continues three decade decline, but steeper increases in incidence for some women

4.

Scientists develop novel adjuvant delivery system to enhance cancer vaccine effectiveness

5.

De-escalation Misses the Mark in Inflammatory Breast Cancer


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot